ESCITALOPRAM OXALATE PRE SOLICITATION SPE2D218R0022 CANCELLED
307c2d4395ec48cc95d70dd5a5e2dbc6 · DEPT OF DEFENSE
A PHARMACEUTICAL PREPARATION MANUFACTURING solicitation. AwardCast estimates what this specific solicitation will close for, before you bid.
What's being bought
Pre-solicitation notice under SPE2D2-18-R-0022 Escitalopram Oxalate Tablets is hereby cancelled. No soliciation will be issued under this Pre-solicitation number SPE2D2-18-R-0022.
Comparable recent awards in PHARMACEUTICAL PREPARATION MANUFACTURING
| Winner | Award value | Offers | Date |
|---|---|---|---|
| PRIORITY HEALTHCARE DISTRIBUTION INC | $16K | 1 | 2026-07-02 |
| REGIMED MEDICAL | $293K | 7 | 2026-07-02 |
| COVERMYMEDS PHARMACY LLC | $16K | 1 | 2026-07-02 |
| SRI INTERNATIONAL | $49.9M | 7 | 2026-07-02 |
| UNITED THERAPEUTICS CORP | $17K | 1 | 2026-07-02 |
Questions
What is solicitation 307c2d4395ec48cc95d70dd5a5e2dbc6?
ESCITALOPRAM OXALATE PRE SOLICITATION SPE2D218R0022 CANCELLED, issued by DEPT OF DEFENSE, under NAICS 325412 (PHARMACEUTICAL PREPARATION MANUFACTURING).
What do similar contracts close for?
Comparable closed awards in this category ran from $16K to $49.9M, across 5 awards shown above. Those are historical results, not a forecast for this solicitation.
Explore the market
Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.
Every forecast is scored against the real award once it becomes public. See the track record.
Closed awards from public federal data, not the forecast. One email, no account.
Or get the forecast for this solicitation — $49, one report.